SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001113148-21-000024
Filing Date
2021-11-02
Accepted
2021-11-02 16:08:51
Documents
14
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K infi-20211102.htm   iXBRL 8-K 40688
2 EX-99.1 pressrelease2021q310q.htm EX-99.1 88267
6 GRAPHIC headera03a.jpg GRAPHIC 24003
  Complete submission text file 0001113148-21-000024.txt   313998

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20211102.xsd EX-101.SCH 1890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20211102_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20211102_pre.xml EX-101.PRE 13038
7 EXTRACTED XBRL INSTANCE DOCUMENT infi-20211102_htm.xml XML 11559
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 211371358
SIC: 2834 Pharmaceutical Preparations